[
  {
    "ts": null,
    "headline": "Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know",
    "summary": "Recently, Zacks.com users have been paying close attention to Amgen (AMGN). This makes it worthwhile to examine what the stock has in store.",
    "url": "https://finnhub.io/api/news?id=e50d85d378e062aa1f1be8c3f9f1d5ffbbe14587b869ef7316a82dbd74c7251b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756848346,
      "headline": "Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know",
      "id": 136613178,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "Recently, Zacks.com users have been paying close attention to Amgen (AMGN). This makes it worthwhile to examine what the stock has in store.",
      "url": "https://finnhub.io/api/news?id=e50d85d378e062aa1f1be8c3f9f1d5ffbbe14587b869ef7316a82dbd74c7251b"
    }
  },
  {
    "ts": null,
    "headline": "Sector Update: Health Care Stocks Retreat Late Afternoon",
    "summary": "Health care stocks declined late Tuesday afternoon, with the NYSE Health Care Index down 0.2% and th",
    "url": "https://finnhub.io/api/news?id=6ceab58ba8d12d9e0aff36fe57e4721631046600c903511150f0034f4cd1bacb",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756846476,
      "headline": "Sector Update: Health Care Stocks Retreat Late Afternoon",
      "id": 136613179,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "Health care stocks declined late Tuesday afternoon, with the NYSE Health Care Index down 0.2% and th",
      "url": "https://finnhub.io/api/news?id=6ceab58ba8d12d9e0aff36fe57e4721631046600c903511150f0034f4cd1bacb"
    }
  },
  {
    "ts": null,
    "headline": "Leerink Partners Maintains a Hold on Amgen (AMGN)",
    "summary": "Amgen Inc. (NASDAQ:AMGN) is one of the best affordable growth stocks to buy. Leerink Partners analyst David Risinger maintained their neutral stance on Amgen Inc. (NASDAQ:AMGN) on August 26, giving the stock a Hold rating. The analyst told investors in a research note that he expects the recent approval of Repatha’s expanded label to boost […]",
    "url": "https://finnhub.io/api/news?id=147ddaf5045f4c252cf5c75c8f5a5c6819d1baf5feabb83405bdda8ad0e5060a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756829577,
      "headline": "Leerink Partners Maintains a Hold on Amgen (AMGN)",
      "id": 136613180,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "Amgen Inc. (NASDAQ:AMGN) is one of the best affordable growth stocks to buy. Leerink Partners analyst David Risinger maintained their neutral stance on Amgen Inc. (NASDAQ:AMGN) on August 26, giving the stock a Hold rating. The analyst told investors in a research note that he expects the recent approval of Repatha’s expanded label to boost […]",
      "url": "https://finnhub.io/api/news?id=147ddaf5045f4c252cf5c75c8f5a5c6819d1baf5feabb83405bdda8ad0e5060a"
    }
  },
  {
    "ts": null,
    "headline": "Nio, Signet Jewelers, Amgen: Trending Tickers",
    "summary": "Market Catalysts host Julie Hyman touches on this morning's top trending stock tickers, including Nio (NIO) after the EV developer reported its second quarter results, Signet Jewelers (SIG) latest earnings beat, and Amgen's (AMGN) $600 million investment into a US research facility. To watch more expert insights and analysis on the latest market action, check out more Market Catalysts.",
    "url": "https://finnhub.io/api/news?id=7fdde1d9a9b21c9b8a2f0ba2df635dd9bcd16aa81dc0e6184d38b424996678b0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756824006,
      "headline": "Nio, Signet Jewelers, Amgen: Trending Tickers",
      "id": 136607398,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "Market Catalysts host Julie Hyman touches on this morning's top trending stock tickers, including Nio (NIO) after the EV developer reported its second quarter results, Signet Jewelers (SIG) latest earnings beat, and Amgen's (AMGN) $600 million investment into a US research facility. To watch more expert insights and analysis on the latest market action, check out more Market Catalysts.",
      "url": "https://finnhub.io/api/news?id=7fdde1d9a9b21c9b8a2f0ba2df635dd9bcd16aa81dc0e6184d38b424996678b0"
    }
  },
  {
    "ts": null,
    "headline": "AMGEN INVESTING MORE THAN HALF A BILLION DOLLARS IN NEW, STATE-OF-THE-ART CENTER FOR SCIENCE AND INNOVATION AT U.S. GLOBAL HEADQUARTERS",
    "summary": "Amgen (NASDAQ: AMGN) today announced plans to invest more than $600 million in a new, state-of-the-art center for science and innovation at its global headquarters in Thousand Oaks, California.",
    "url": "https://finnhub.io/api/news?id=e86cc5cdea947652a5a64430a431ec2cff12528bbe2879f23facb52e6c910fbe",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756821660,
      "headline": "AMGEN INVESTING MORE THAN HALF A BILLION DOLLARS IN NEW, STATE-OF-THE-ART CENTER FOR SCIENCE AND INNOVATION AT U.S. GLOBAL HEADQUARTERS",
      "id": 136613182,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "Amgen (NASDAQ: AMGN) today announced plans to invest more than $600 million in a new, state-of-the-art center for science and innovation at its global headquarters in Thousand Oaks, California.",
      "url": "https://finnhub.io/api/news?id=e86cc5cdea947652a5a64430a431ec2cff12528bbe2879f23facb52e6c910fbe"
    }
  },
  {
    "ts": null,
    "headline": "Amgen to invest $600M in new US center; Sanofi drug for ITP approved",
    "summary": "The new \"science and innovation center\" will be built at Amgen's headquarters in Thousand Oaks, California. Elsewhere, Wayrilz became the first BTK blocker cleared for immune thrombocytopenia.",
    "url": "https://finnhub.io/api/news?id=dc583b6f8e59ac5179a804f53579185d7c9bc4927208b2e17bb4197fb15c486a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756815600,
      "headline": "Amgen to invest $600M in new US center; Sanofi drug for ITP approved",
      "id": 136608888,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "The new \"science and innovation center\" will be built at Amgen's headquarters in Thousand Oaks, California. Elsewhere, Wayrilz became the first BTK blocker cleared for immune thrombocytopenia.",
      "url": "https://finnhub.io/api/news?id=dc583b6f8e59ac5179a804f53579185d7c9bc4927208b2e17bb4197fb15c486a"
    }
  },
  {
    "ts": null,
    "headline": "Amgen to Invest $600 Million at California Headquarters",
    "summary": "Amgen to Invest $600 Million at California Headquarters",
    "url": "https://finnhub.io/api/news?id=89bbce29d7790fe0413761fb0b9ae9c8dc87a516799eefc9015238c77cc81242",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756807080,
      "headline": "Amgen to Invest $600 Million at California Headquarters",
      "id": 136619500,
      "image": "",
      "related": "AMGN",
      "source": "MarketWatch",
      "summary": "Amgen to Invest $600 Million at California Headquarters",
      "url": "https://finnhub.io/api/news?id=89bbce29d7790fe0413761fb0b9ae9c8dc87a516799eefc9015238c77cc81242"
    }
  },
  {
    "ts": null,
    "headline": "Amgen Inc. (AMGN)’s Experimental Obesity Drug MariTide Shows Up to 20% Weight Loss Potential",
    "summary": "We recently compiled a list of the 10 High Growth Pharma Stocks That Are Profitable in 2025. Amgen Inc. is one of them, Amgen Inc. (NASDAQ:AMGN), the California-based biotech giant, continues to strengthen its leadership in cardiovascular, oncology, respiratory, and rare diseases while expanding into new therapeutic frontiers. In Q2 2025, the company posted a […]",
    "url": "https://finnhub.io/api/news?id=5139a548d5e6fe78d6d3750a05ab254dc783387f6eb5d93f7b8e54b1ce8f138c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756801784,
      "headline": "Amgen Inc. (AMGN)’s Experimental Obesity Drug MariTide Shows Up to 20% Weight Loss Potential",
      "id": 136604266,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "We recently compiled a list of the 10 High Growth Pharma Stocks That Are Profitable in 2025. Amgen Inc. is one of them, Amgen Inc. (NASDAQ:AMGN), the California-based biotech giant, continues to strengthen its leadership in cardiovascular, oncology, respiratory, and rare diseases while expanding into new therapeutic frontiers. In Q2 2025, the company posted a […]",
      "url": "https://finnhub.io/api/news?id=5139a548d5e6fe78d6d3750a05ab254dc783387f6eb5d93f7b8e54b1ce8f138c"
    }
  }
]